HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemotherapy improves the survival of patients with choroid plexus carcinoma: a meta-analysis of individual cases with choroid plexus tumors.

AbstractBACKGROUND:
Choroid plexus carcinomas (CPC) are rare brain tumors with a dismal prognosis. Although the role of surgery has been well established, the question of whether chemotherapy improves the prognosis is still under discussion.
METHODS:
We created a database of all cases of choroid plexus tumors (CPT) reported in the literature up to the year 2004 to determine prognostic factors and different therapeutic modalities. This database was validated by comparison with an existing database of cases until 1997.
RESULTS:
Of 857 documented cases of CPT (median patient age at diagnosis, 3 years), 347 were CPC, 15 atypical choroid plexus papilloma (APP), and 495 choroid plexus papilloma (CPP). Histology was a significant prognostic factor (P < .0001; log rank). Within the subgroup of patients with CPC, both surgery and irradiation were linked to a better prognosis (P < .005). The 104 CPC patients who received chemotherapy had a statistically better survival than those without chemotherapy (P = .0004). When subgroups were defined by radiation treatment, chemotherapy remained beneficial in the subgroup of nonirradiated tumors (P = .0001). The benefit of chemotherapy was also significant when the analysis was restricted to the subgroup of patients with less than completely resected CPC (2-year overall survival (OS) 54.8 +/- 7% (standard deviation (SD) vs. 24.4 +/- 7%, P < .0001) and when this subgroup was further divided into smaller subgroups. Likewise, in a multivariate analysis, chemotherapy was highly significantly linked to better prognosis (P = .0001).
CONCLUSION:
Patients with less than completely resected CPC should receive chemotherapy.
AuthorsBrigitte Wrede, Ping Liu, Johannes Ernst Alexander Wolff
JournalJournal of neuro-oncology (J Neurooncol) Vol. 85 Issue 3 Pg. 345-51 (Dec 2007) ISSN: 0167-594X [Print] United States
PMID17576522 (Publication Type: Journal Article, Meta-Analysis)
Chemical References
  • Antineoplastic Agents
Topics
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Carcinoma (drug therapy, mortality, pathology, radiotherapy)
  • Child
  • Child, Preschool
  • Choroid Plexus Neoplasms (drug therapy, mortality, pathology, radiotherapy)
  • Combined Modality Therapy
  • Databases, Bibliographic
  • Databases, Factual
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Prognosis
  • Survival Analysis
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: